Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis
| Autor: | Glicksman, R.M. ∗, Kishan, A.U. †, Katz, A.J. ‡, Mantz, C.A. §, Collins, S.P. ¶, Fuller, D.B. ||, Steinberg, M.L. †, Shabsovich, D. †, Zhang, L. ∗∗, Loblaw, A. ∗∗, †† |
|---|---|
| Zdroj: | In Clinical Oncology January 2022 34(1):36-41 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect